Pharma Reviews: Zuckerberg Plans to Sell as Much as 18% of His Facebook Shares

Has anything fundamentally changed for Indian pharma companies? Is it time to re-look at some of the pharma names or you still remain cautious?
Read more: Zuckerberg Plans to Sell as Much as 18% of His Facebook Shares